explore -WSS

explore

author：knowledge 2025-09-30 05:00:04 - browse：3

Cambridge: Biogen — Ruby Wallau for STAT

Biogen, the iconic but embattled biotech firm, is shuttering Biogen Digital Health, its roughly 150-person group focused on using new types of data like those from mobile phones and smart watches, and ending a clinical trial being conducted with Apple early, STAT has learned.

Biogen confirmed the organizational change, but said it might lean even more on digital tech startups in the future.

“It’s certainly not an abandonment of digital, it’s more of a realignment of resources and priorities,” said Adam Keeney, Biogen’s executive vice president and head of corporate development. However, he later acknowledged, Biogen Digital Health, a separate entity, “would no longer continue in its current form.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： As demand for Covid shots wanes, Moderna seeks its next success
Next article： JPM: CVS says Medicare Advantage patients are impacting profits

WSS

Federal weight loss drug coverage is 30 years out of date

HHS leader on health, climate change and biopharma emissions

HHS leader on health, climate change and biopharma emissions

The biotech scorecard for Q1: 17 stock

At JPM, Bristol Myers Squibb CEO tries to soothe investor nerves

Why health workers in Gaza are injured or die at high rates

hotspot

explore

leisure time

Moonlake's readout produced a cash windfall. Risks remain

STAT Readout Newsletter: Today's biggest biotech updates

Bright Health sells Medicare Advantage business to Molina

STAT Summit: Michael J. Fox on progress in Parkinson's research

In Memoriam: Notable people who died in 2023

Will Ozempic

Dobbs anniversary: the lost opportunity of abortion as health care

Feng Zhang CRISPR delivery startup lays off quarter of staff

New air purifier tech could be key to improving indoor air quality

JPM: CVS says Medicare Advantage patients are impacting profits

hotspot

Medicare reduced heart disease by changing how it pays doctors

The FDA must approve intranasal treatments for anaphylaxis

Lawmakers consider Medicare pay reforms for doctors

Lawmakers consider Medicare pay reforms for doctors

JPM: CVS says Medicare Advantage patients are impacting profits

STAT Summit: How a Chicago ER doctor tackles gun violence

entertainment

hotspot

entertainment

leisure time